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The importance of IL-12p70 in the CD4 T cell 
response to Mycobacterium tuberculosis (Mtb) has 
been demonstrated both experimentally (1–3) 
and by the increased susceptibility of humans 
defi  cient in the IL-12 pathway to tuberculo-
sis (4, 5) and other mycobacterial infections 
(6–8). IL-12p70 is made up of IL-12p35 and 
IL-12p40 (9). In murine models of tubercu-
losis, IL-12p35 defi  ciency is less detrimental 
to host response than IL-12p40 defi  ciency 
(2, 3),   suggesting that IL-12p40 has IL-12p35–
  independent bioactivity.
Three cytokines use the IL-12p40 sub-
unit: IL-12p70, IL-23 (p40 and p19) (10), and 
IL-12(p40)2 (homodimeric IL-12p40; see Table 
I) (9). The majority of the   protective response 
to tuberculosis in the absence of IL-12p70 is 
dependent on IL-23 (11); however, exogenous 
IL-12(p40)2 partially restores protection in my-
cobacteria-infected IL-12p40–defi  cient  mice 
(2). How IL-12(p40)2 aff  ects the cellular re-
sponse to Mtb is unknown. IL-12(p40)2 cannot 
induce IFN-γ production in T cells and blocks 
IL-12p70 activation of T cells (9). Myeloid 
cells express the IL-12R (12–14), the ligation 
of which initiates NF-κB migration (12, 15, 16). 
IL-12(p40)2 also acts as a chemoattractant for 
macrophages (14) and induces TNF-α (17) 
and nitric oxide synthase (18). Thus, IL-12p40 
has the potential to directly modify myeloid 
cell activity.
The DC population lining the lung is 
key to the initiation of T cell responses af-
ter   pulmonary challenge (19). These cells re-
main quiescent until activated to migrate to 
the draining LN (DLN) (20), present antigen, 
and initiate T cell activation (21). Eff  ector cell 
development depends upon whether DCs 
are stimulated to produce IL-12p70 (22, 23). 
  Although this role of DC-derived IL-12p70 is 
accepted, the early secretion of only IL-12p40 
during lung infl  ammation (24–26) supports an 
independent function for IL-12p40.
Here we investigate the role of IL-12p40 
in DC migration from the lung to the DLN 
and in activation of CD4 T cells. We show 
that IL-12p40 defi  ciency results in reduced 
migration of DCs and reduced activation 
of naive T cells. This defi  ciency is not seen 
in mice that express only IL-12p40 and can 
be overcome with exogenous IL-12(p40)2. 
These data support a novel and important 
role for IL-12p40 in initiation of the adaptive 
immune response to bacterial challenge in 
the lung.
Interleukin 12p40 is required for dendritic 
cell migration and T cell priming after 
Mycobacterium tuberculosis infection
Shabaana A. Khader,1 Santiago Partida-Sanchez,1 Guy Bell,1 
Dawn M. Jelley-Gibbs,1 Susan Swain,1 John E. Pearl,1 Nico Ghilardi,2 
Frederic J. deSauvage,2 Frances E. Lund,1 and Andrea M. Cooper1
1Trudeau Institute, Inc., Saranac Lake, NY 12983
2Genentech Inc., South San Francisco, CA 94080
Migration of dendritic cells (DCs) to the draining lymph node (DLN) is required for the 
activation of naive T cells. We show here that migration of DCs from the lung to the DLN 
after Mycobacterium tuberculosis (Mtb) exposure is defective in mice lacking interleukin 
(IL)-12p40. This defect compromises the ability of IL-12p40–defi  cient DCs to activate 
naive T cells in vivo; however, DCs that express IL-12p40 alone can activate naive T cells. 
Treatment of IL-12p40–defi  cient DCs with IL-12p40 homodimer (IL-12(p40)2) restores 
Mtb-induced DC migration and the ability of IL-12p40–defi  cient DCs to activate naive 
T cells. These data defi  ne a novel and fundamental role for IL-12p40 in the pathogen-
induced activation of pulmonary DCs.
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RESULTS
Mice lacking IL-12p40 fail to generate activated CD4 
T cells after Mtb infection
Induction of antigen-specifi  c CD4+ T cells in response to 
respiratory pathogens such as Mtb is required to mediate pro-
tection. In previous studies we showed that in the absence of 
IL-12p70, both antigen-specifi  c IFN-γ and delayed-type hy-
persensitivity responses were induced after Mtb infection but 
that in the absence of IL-12p40, no such responses could be 
detected (3). To confi  rm that Mtb-specifi  c IFN-γ–produc-
ing CD4 T cells depend upon IL-12p40 for their induction, 
we used an IAb-restricted peptide of an immunodominant 
Mtb antigen (ESAT-61–20) to analyze the CD4+ T cell re-
sponse in gene-defi  cient mice. We show that in the absence 
of IL-12p40, very few ESAT-specifi  c  IFN-γ–producing 
CD4 T cells accumulate in the lung by day 21 (Fig. 1 a). In 
contrast, both IL-23p19–defi   cient and IL-12p35–defi  cient 
mice accumulate a signifi  cant number of ESAT-specifi  c 
IFN-γ–producing CD4 T cells, although this response is re-
duced in the IL-12p35–defi  cient compared with the B6 and 
IL-23p19–defi  cient mice (Fig. 1 a). We have recently shown 
that the residual IFN-γ–producing CD4+ T cell eff  ector re-
sponse observed in the IL-12p35–defi  cient mice is due to 
IL-23 as this response is lost in the IL-12p35–/IL-23p19–
  defi  cient mice (11). However, we have not determined the 
relative roles of IL-23 and IL-12p40 on activation of naive 
T cells after Mtb infection. Therefore, to determine whether 
IL-12p40 alone can initiate CD4 T cell activation after Mtb 
infection, we measured the total number of activated (i.e., 
CD44high) CD4 T cells accumulating in the lung at day 20 
after infection in B6 and gene-defi  cient mice. As shown in 
Fig. 1 b, the number of activated CD4 T cells in the lung of 
normal mice increases signifi  cantly upon infection with Mtb, 
but this response is reduced in the absence of IL-12p40. 
In contrast, mice that express IL-12p40 alone accumulate a 
signifi  cantly higher number of activated CD4+ T cells upon 
infection than in the absence of IL-12p40. These data dem-
onstrate that the absence of IL-12p40 is detrimental to the 
induction of activated CD4 T cells within the lung and that 
although generation of IFN-γ–producing eff   ector cells is 
  dependent on IL-12p70 and IL-23, the accumulation of 
activated CD4 T cells within the lung can be initiated by 
IL-12p40 alone.
IL-12p40–defi  cient DCs can activate naive CD4 T cells 
when not required to migrate
The ability of IL-12(p40)2 to mediate protection against my-
cobacterial disease (2), as well as our data indicating a unique 
role for IL-12p40 in T cell activation (Fig. 1 b), makes un-
derstanding the function of this cytokine subunit in T cell 
responses to Mtb an important goal. As DCs are key to the 
activation of naive cells and also express IL-12R subunits, 
we began by analyzing the eff  ect of IL-12p40 defi  ciency 
on DC function. Initially, we investigated the ability of 
Figure 1.  T cell activation after Mtb infection requires IL-12p40. 
(a) B6 (fi  lled circle), IL-23p19–defi  cient (open triangle), IL-12p35–defi  cient 
(open square), and IL-12p40–defi  cient (open circle) mice were infected with 
 75 CFU Mtb via the aerosol route, and the number of antigen-specifi  c 
IFN-γ–producing CD4 T cells in the lung on day 21 was determined by 
ELISPOT. Data points represent the mean number of Th1 cells/time point 
(n = 4). One experiment representative of three total experiments is shown. 
The dashed line represents the limit of detection for this assay. **, P ≤ 0.001 
relative to B6 value determined by Student’s t test. (b) The number of 
  activated CD4 T cells in the lungs of mice infected for 21 d was determined 
by fl  ow cytometry. Data points represent the mean number of T cells/time 
point (n = 8–16). p-values were determined by the Student’s t test.
Figure 2.  IL-12p40–defi  cient BMDCs can stimulate naive T cells 
if not required to migrate. BMDCs were generated from B6 and IL-
12p40–defi  cient (p40KO) mice and either treated with Mtb (fi  lled bars) 
or left uninfected (striped bars) and pulsed with OVA323–339. Naive OVA-
specifi  c TCRTg CD4 T cells were cultured with the BMDCs for 3 d. The 
number (a) and phenotype (b) of cells present on day 3 were determined. 
Data points represent the mean of each group (n = 3). One experiment 
representative of two total experiments is shown. p-values were deter-
mined by the Student’s t test. (c) BMDCs were generated as described for 
(a) and delivered intravenously into mice that had previously received 
naive TCRTg OVA-specifi  c T cells. The number of T cells was determined at 
day 4. Data points represent the mean number of T cells (n = 3–4). One 
experiment is shown. (d) BMDCs from B6 (fi  lled circles), IL-12p40–defi  cient 
(open circles), and IL-12p35–defi  cient (open squares) mice were cultured 
with Mtb, and the amount of IL-10 released over time was determined by 
ELISA. Data points represent the mean for each group (n = 3). One ex-
periment representative of two total experiments is shown. *, P ≤ 0.01 for 
the difference between B6 and IL-12p40–defi  cient BMDCs as determined 
by the Student’s t test.JEM VOL. 203, July 10, 2006  1807
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IL-12p40–defi  cient bone marrow–derived DCs (BMDCs) 
activated by Mtb to present cognate antigen (OVA323–339 
peptide) to naive TCR transgenic (Tg; OT-II) CD4 T cells 
both in vitro and in vivo. The IL-12p40–defi  cient BMDCs 
were not compromised in their ability to initiate T cell acti-
vation in response to antigen in vitro, as T cell expansion 
was equivalent in cultures stimulated by B6 or IL-12p40–de-
fi  cient BMDCs (Fig. 2 a). CD44 was also up-regulated on 
CD4 T cells after activation by IL-12p40–defi  cient BMDCs 
as shown by the equivalent numbers of CD4+CD44high cells 
in the wells stimulated by B6 and IL-12p40–defi  cient BM-
DCs (Fig. 2 b). When IL-12p40–defi  cient BMDCs were 
exposed to Mtb, loaded with OVA323–339, and delivered in-
travenously into mice that had received a bolus of naive OT-II 
TCRTg CD4 T cells, they were able to stimulate T cell ex-
pansion (Fig. 2 c) as eff  ectively as B6 BMDCs. These data 
indicate that IL-12p40–defi  cient DCs are capable of induc-
ing expansion and activation of naive CD4 T cells when the 
DCs are in close proximity (either in vitro or in vivo) with 
naive T cells.
To determine whether IL-12p40 modulates the DC 
  response to Mtb, we measured cytokine mRNA and protein 
and found that IL-12p40–defi  cient DCs generate more IL-10 
both at the mRNA (not depicted) and protein level than B6 
DCs (Fig. 2 d). These data indicate that although Mtb-
  exposed IL-12p40–defi  cient DCs are able to activate naive 
T cells, IL-12p40 acts to reduce the IL-10 response to Mtb 
in DCs.
IL-12p40–defi  cient mice have an equivalent population 
of DCs in the lung compared with intact mice
We show that activated T cells fail to accumulate in the lungs 
of Mtb-infected IL-12p40–defi   cient mice despite the fact 
that IL-12p40–defi  cient DCs can activate naive T cells. Thus, 
it was possible that DCs were not developing appropriately in 
the lungs of IL-12p40–defi  cient mice and were therefore un-
able to prime T cells in vivo. To determine whether DCs in 
the lungs of naive normal mice diff  er substantially from the 
DCs in the lungs of IL-12p40–defi  cient mice, we used a sim-
ple set of criteria to identify and characterize lung DCs. We 
stained for the integrin CD11c, a marker expressed by most 
DCs (27), and gated on CD11c+ cells that have low autofl  u-
orescence, as these cells have been characterized as lung DCs 
(28). Using this designation, we determined that there are 
similar numbers of total lung cells (Fig. 3 a), CD11c+ cells 
(Fig. 3 b), and DCs (Fig. 3 c) in B6, IL-12p35–defi  cient, IL-
23p19–defi  cient, and IL-12p40–defi  cient mice. To further 
characterize these cells we also stained for MHC class II (Fig. 
3 d), CD80, CD86, and CD40 (not depicted) expression and 
found that the apparent activation state of these cells in naive 
mice is equivalent regardless of the availability of the IL-
12p40–dependent cytokines. These data indicate that in the 
steady-state lung, DCs are not substantially altered in terms of 
number or activation state in the absence of IL-12p40. There 
are no signifi  cant detectable changes in the numbers or phe-
notype of myeloid cells in the lung during the fi  rst 20 d of 
low-dose aerosol infection (not depicted).
Figure 3.  IL-12p40–defi  cient steady-state lung DCs are not com-
promised. The number of total live cells (a), the total number of CD11c+ 
cells (b), and the total number of low autofl  uorescence CD11c+ cells was 
determined (c). Data points represent the mean for each group (n = 5). 
One experiment representative of two total experiments is shown. The 
expression MHC class II was analyzed on low-autofl  uorescence CD11c+ 
cells (d). Black histogram represents the isotype control, gray histogram 
represents B6 cells, and the open line shows expression of class II on 
IL-12p40–defi  cient (p40KO) cells. One mouse representative for each 
group is shown.
Figure 4.  Pathogen-activated DCs fail to migrate from the lungs 
of IL-12p40–defi  cient mice. CFSE and either LPS (a) or irradiated Mtb 
(b) were delivered intratracheally to B6 and gene-defi  cient mice, and the 
frequency of CFSE-labeled CD11c+ cells in the DLN and lung was deter-
mined by fl  ow cytometry after 18 h. Data points represent the mean for 
each group (n = 3–4). One experiment representative of two total experi-
ments is shown. p-values were determined by the Student’s t test. 
(c) Representative histogram illustrating the population of CFSE+CD11c+ 
cells within the DLNs of B6 and gene-defi  cient mice at 18 h after delivery 
of Mtb to the lungs of CFSE-treated mice.1808  IL-12P40 AND DENDRITIC CELL MIGRATION IN THE LUNG | Khader et al.
DCs fail to migrate from the lungs of IL-12p40–defi  cient 
mice after pathogen exposure
Because the DCs in the lungs of the IL-12p40–defi  cient mice 
are present in normal numbers, we next considered whether 
these DCs were able to respond to Mtb challenge and mi-
grate from the lung to the DLN (21). Therefore, we labeled 
cells in the airways of B6 and gene-defi  cient mice with CFSE 
and activated the DCs by administering LPS or irradiated 
Mtb intratracheally. We then determined the frequency of 
CFSE+/CD11c+ DCs within the DLN 18 h after delivery 
(Fig. 4). We found that the frequency of CD11c+/CFSE+ 
DCs in the DLNs of B6 mice exposed to either LPS (Fig. 4 a) 
or Mtb (Fig. 4 b) was signifi  cantly increased compared with 
mice that received CFSE alone (Fig. 4, a and b; there was no 
diff  erence in frequency or number of CFSE+/CD11c+ cells 
in the DLNs of B6, IL-12p35–defi  cient, or IL-12p40–defi  cient 
mice treated with CFSE alone). However, there was a signif-
icantly reduced frequency of CD11c+/CFSE+ DCs in the 
DLNs of IL-12p40–defi   cient mice challenged with either 
agent (Fig. 4, a and b). Although the IL-12p35–defi  cient 
mice had a slightly lower frequency of CD11c+CFSE+ cells 
in the DLNs than the B6 mice, this reduction did not reach 
signifi  cance and these mice had a signifi  cantly higher response 
to both agents compared with IL-12p40–defi  cient mice (Fig. 
4, a and b). These data demonstrate that in the absence of 
IL-12p40, CD11c+ cells are less able to migrate from the 
lung to the DLN.
The experiment described above does not distinguish an 
intrinsic defect in the IL-12p40–defi  cient DCs from defec-
tive signaling within the gene-defi  cient lung interstitium. 
To address this issue, we generated BMDCs from B6 and 
gene-defi  cient mice, activated these cells with Mtb for 3 h, 
and labeled them with TAMRA orange. These cells were 
then delivered intratracheally into the lungs of B6 mice, and 
the frequency of TAMRA-labeled CD11c+ cells in the DLN 
was determined by fl  ow cytometry (Fig. 5 a). We found that 
the frequency and total number of Mtb-activated, B6, IL-
23p19–defi   cient, and IL-12p35–defi   cient BMDCs within 
the DLNs of the host mice was equivalent (Fig. 5 b). In con-
trast, there were many fewer BMDCs from IL-12p40–defi  -
cient mice in the DLNs (Fig. 5 b). The fact that the transferred 
IL-12p40–defi  cient BMDCs remained in the lung at a higher 
frequency and total number than the BMDCs from the B6, 
IL-23p19–defi  cient, and IL-12p35–defi  cient mice supports 
the hypothesis that these cells were not able to move from 
the lung to the DLN (Fig. 5 c). We conclude that DCs acti-
vated by Mtb need to be able to produce IL-12p40, but not 
IL-23 or IL-12p70, to be able to migrate from the lung to 
the DLN.
BMDCs from IL-12p40–defi  cient mice fail 
to become responsive to chemokines after exposure 
to Mtb but can be rescued by IL-12(p40)2
The inability of BMDCs from IL-12p40–defi  cient  mice 
to migrate to the DLN after transfer suggested that Mtb-
  exposed DCs might not be capable of traffi   cking to the LN due 
to an inability to respond to specifi  c chemokine signals. One 
facet of DC activation in response to microbial stimuli is the 
increased ability of these cells to respond to homeostatic che-
mokines such as CCL19 and CCL21 that facilitate migration 
to the LN. To determine whether the IL-12p40–defi  cient 
BMDCs are less able to respond to homeostatic chemokines 
after Mtb exposure, we performed in vitro transwell migra-
tion assays on Mtb-activated BMDCs from B6 and gene-
defi  cient mice. We found that BMDCs not exposed to Mtb 
exhibited limited migration in response to the CCR7 ligands 
CCL19 (Fig. 6 a) or CCL21 (not depicted), but after a 3-h 
exposure to Mtb, B6 and IL-23p19–defi  cient BMDCs mi-
grated effi   ciently in response to both chemokines. In contrast, 
the IL-12p40–defi  cient BMDCs were unable to up-regulate 
their response to either chemokine even after exposure to 
Mtb (Fig. 6 a). IL-12p35–defi  cient BMDCs responded to 
chemokines signifi  cantly better than the IL-12p40–defi  cient 
BMDCs after Mtb exposure, but this response was reduced 
compared with the B6 BMDCs (Fig. 6 a). We also com-
pared induction of the ccr7 gene, which encodes the prin-
cipal CCL19 and CCL21 receptor CCR7, between B6 and 
IL-12p40–defi  cient BMDCs over the 3-h exposure to Mtb. 
Figure 5.  BMDCs from IL-12p40–defi  cient mice fail to migrate 
from the lung when activated by Mtb. BMDCs from B6 and gene-
 defi  cient mice were exposed to irradiated Mtb for 3 h, washed, labeled 
with TAMRA orange, and delivered intratracheally to B6 mice. The frequency 
(a) and number (b) of CD11c+/TAMRA-labeled cells within the DLN was 
then determined over time using fl  ow cytometry. The frequency and number 
of CD11c+/TAMRA-labeled cells within the lung were also determined on 
day 2 (fi  lled bars) and day 4 (striped bars) (c). Data points represent the 
mean for each group (n = 3–4). One experiment representative of two total 
experiments is shown. p-values were determined by the Student’s t test.JEM VOL. 203, July 10, 2006  1809
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We found that this gene is poorly induced in the Mtb-treated 
IL-12p40–defi  cient BMDCs compared with the Mtb-treated 
B6 BMDCs (Fig. 6 b). These data demonstrate that IL-
12p40–defi  cient DCs have a compromised response to Mtb 
in that they fail to up-regulate the mRNA for the chemokine 
receptor associated with migration.
Because IL-12p40–defi   cient mice lack both IL-12p40 
and IL-12p70, we next asked whether IL-12p40 alone was 
suffi   cient to induce the diff  erentiation of DCs into cells capa-
ble of migrating in response to CCL19. Therefore, we tested 
the ability of BMDCs containing only IL-12p40 (i.e., 
IL-23p19–/IL-12p35–defi  cient) to become responsive to 
CCL19 when exposed to Mtb. These BMDCs were as able 
as B6 BMDCs to migrate to CCL19 after Mtb exposure (Fig. 
6 c), indicating that IL-12p40 was suffi   cient for the develop-
ment of this phenotype. Similarly, the addition of exogenous 
IL-12(p40)2 for the 3-h period of Mtb exposure dramatically 
increased the ability of IL-12p40–defi  cient BMDCs to mi-
grate in response to CCL19 (Fig. 6, c and d), albeit not to the 
level seen in B6 BMDCs. To confi  rm the specifi  city of the 
IL-12(p40)2 reagent, it was denatured by boiling. This ab-
lated its ability to restore migration in the IL-12p40–defi  cient 
BMDCs (Fig. 6 d). The addition of IL-12p70 was also unable 
to restore migration in the IL-12p40–defi  cient BMDCs (Fig. 
6 d). As IL-12p40–defi  cient BMDCs produce more IL-10 
upon exposure to Mtb than B6 BMDCs (Fig. 2 d), we deter-
mined whether exogenous IL-10 could recapitulate the IL-
12p40–defi  cient BMDC phenotype. Indeed, the addition of 
IL-10 to Mtb-activated B6 BMDCs reduced the responsive-
ness of these cells to CCL19 to background level (Fig. 6 e). 
The addition of IL-10 also signifi  cantly reduced the Mtb-in-
duced IL-12p40 produced by the Mtb-activated B6 BMDCs 
(Fig. 6 f). Collectively, these data confi  rm that IL-12p40, 
probably in the form of IL-12(p40)2, is suffi   cient to mediate 
the Mtb-induced migratory phenotype in DCs and that a 
balance between IL-10 and IL-12p40 may dictate the ability 
of BMDCs to respond to CCL19.
Failure of BMDCs to migrate from the lung to the DLN 
dramatically compromises the ability of the cells 
to activate antigen-specifi  c cells in vivo
To determine whether reduced migration of DCs from the 
lung to the DLN seen in the IL-12p40–defi  cient mice re-
sults in reduced activation of naive antigen-specifi  c CD4+ 
T cells, we pulsed Mtb-activated BMDCs with OVA323–339 
and transferred these cells into the lungs of B6 mice that had 
received a bolus of naive OVA-specifi  c TCRTg (OT-II) 
CD4 T cells 48 h previously. The ability of the transferred 
DCs to initiate activation of naive T cells was measured by 
the frequency of activated (CD44high/CD69high) TCRTg 
T cells within the LN (Fig. 7 a). The data demonstrate that 
intratracheal delivery of Mtb-activated OVA323–339-pulsed 
Figure 6.  IL-12p40–defi  cient DCs fail to become responsive to 
homeostatic chemokines when stimulated by Mtb. BMDCs from B6 
and gene-defi  cient mice were either left uninfected or infected with Mtb 
for 3 h. BMDCs were then placed in the upper chamber of a transwell 
plate and CCL19 was added to the lower chamber. The cells that migrated 
from the upper to the lower chamber within 90 min were then counted. 
The data are shown as chemotaxis index, which is the fold increase in 
induced migration over spontaneous migration. (a) The chemotaxis index 
was determined for B6 and gene-defi  cient mice. (b) The mRNA from un-
treated B6 and IL-12p40–defi  cient (p40KO) BMDCs treated with Mtb for 
3 h was analyzed for the relative induction of mRNA for CCR7 by real-
time PCR. The level of ccr7 gene expression in unstimulated B6 and IL-12p40–
defi  cient (p40KO) BMDCs was not signifi  cantly different (not depicted). 
(c) The chemotaxis index for Mtb-activated IL-12p40–defi  cient (p40KO) 
BMDCs treated with IL-12(p40)2 or Mtb-activated BMDCs producing 
IL-12p40 alone was determined. Data points represent the mean for each 
group (n = 3–4). (d) The chemotaxis index for Mtb-activated p40-defi  cient 
BMDCs was determined when IL-12(p40)2, denatured IL-12(p40)2, or 
IL-12p70 was added to p40-defi  cient BMDCs. (e) The chemotaxis index for 
Mtb-activated BMDCs was determined in the presence and absence of 
  exogenous IL-10. (f) The production of IL-12p40 from B6 BMDCs activated 
by Mtb for 3 h in the presence or absence of exogenous IL-10 was determined 
by ELISA. One experiment representative of two total experiments for each 
of panels a–f is shown. p-values were determined by the Student’s t test.1810  IL-12P40 AND DENDRITIC CELL MIGRATION IN THE LUNG | Khader et al.
B6, IL-23p19–defi  cient, or IL-12p35–defi  cient BMDCs re-
sults in the increased accumulation (Fig. 7 b) of activated 
antigen-specifi  c cells (Fig. 7 c; also true for CD44high cells; 
not depicted) within the DLN compared with nonactivated 
BMDCs. Further, although the delivery of BMDCs with 
OVA323–339 alone initiated the expansion of TCRTg cells, 
the expansion was signifi  cantly reduced compared with Mtb-
activated BMDCs (5.43 ± 13 CD44high TCRTg cells in the 
LN after OVA323–339 alone compared with 1.35 ± 2.74 after 
OVA323–339 and Mtb-activated BMDCs; n = 3, P = 0.012 
by Student’s t test). In contrast, the transfer of OVA323–339-
pulsed Mtb-activated IL-12p40–defi  cient DCs resulted in a 
reduced frequency of activated antigen-specifi  c cells (Fig. 7 a)
and a dramatically reduced accumulation of antigen-spe-
cifi  c T cells in the DLN (Fig. 7, b and c). To confi  rm that 
these reduced numbers refl   ected reduced activation of 
T cells, we compared the dilution of CFSE in naive cells after 
the transfer of OVA323–339-pulsed Mtb-activated B6 and IL-
12p40–defi  cient DCs. It is clear that although there is some 
CFSE dilution in those mice receiving IL-12p40–defi  cient 
DCs, this is signifi  cantly reduced compared with those re-
ceiving B6 DCs (Fig. 7 e). These data demonstrate that lung 
DCs can initiate proliferation and activation of naive T cells 
within the DLN and that this ability requires IL-12p40, but 
not IL-12p70 or IL-23, expression by the DC. In light of 
data demonstrating IL-12p40 production from both human 
and murine airway epithelial cells (14, 25, 29), we wanted 
to determine whether host-derived IL-12p40 was required 
for T cell activation. To do this we examined the ability of 
B6 Mtb-activated OVA323–339-pulsed BMDCs to stimulate 
Figure 7.  DCs from IL-12p40–defi  cient mice are unable to activate 
naive T cells when delivered into the lung. BMDCs generated from B6 
and gene-defi  cient mice were exposed to irradiated Mtb for 3 h, pulsed 
with OVA323–339, and delivered intratracheally into mice that had received 
intravenous delivery of naive TCRTg CD4 T cells 48 h earlier. The frequency 
of CD4+CD90.1+ OVA-specifi  c cells in the DLN cells was determined by 
fl  ow cytometry for mice receiving BMDCs from each of the groups (a, top). 
The frequency of activated CD4+CD90.1+ cells in the DLN was also deter-
mined by fl  ow cytometry (a, bottom). The total number of CD4+CD90.1+ 
T cells (b) and the total number of activated CD4+CD90.1+ T cells (c) were 
calculated. ELISPOT was used to determine the number of IFN-γ–producing 
OVA-specifi  c T cells within the DLN (d). Data points represent the mean for 
each group (n = 3–4). One experiment representative of two total experi-
ments is shown. p-values were determined by the Student’s t test. CFSE-
labeled naive TCRTg CD4 T cells were delivered to mice, and the loss of 
CFSE 4 d after intratracheal delivery of B6 or IL-12p40-defi  cient (p40KO) 
BMDCs was determined by fl  ow cytometry (e). Graphs are representative 
of three to seven mice and of two experiments Numbers indicate the mean 
frequency of cells within the undivided and divided gates for each group. 
**, P ≤ 0.005 compared with the B6 values by Student’s t test.JEM VOL. 203, July 10, 2006  1811
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TCRTg T cell expansion in IL-12p40–defi  cient hosts. We 
found that T cell expansion was as effi   cient as for B6 BMDCs 
within B6 hosts (1.55 ± 1.44 CD44high TCRTg cells in the 
LNs of IL-12p40–defi  cient hosts compared with 1.35 ± 2.74 
in B6 hosts; n = 3, P = 0.4563 by Student’s t test). These 
data demonstrate that IL-12p40 from the interstitium is not 
required for the DC-induced expansion of T cells.
DCs not only drive the proliferation and activation of 
  naive T cells, they also facilitate cytokine production by 
the newly activated T cells. Therefore, we measured the fre-
quency of cytokine-producing T cells in the DLNs of the 
mice described above. B6 DCs were able to initiate a Th1 
response within the TCRTg T cells, as were DCs derived 
from IL-23p19–defi  cient mice (Fig. 7 d). In contrast, DCs 
from mice lacking IL-12p70 were substantially compromised 
in their ability to induce a Th1 response, although they were 
signifi  cantly better than DCs from IL-12p40–defi  cient mice 
in this respect (Fig. 7 d). These data demonstrate that the for-
mation of IFN-γ–producing T cells in the LN is dependent 
on IL-12p40 expressed by the DC, and this is due to a large 
degree on IL-12p70.
Availability of IL-12(p40)2 during Mtb activation results 
in the ability of IL-12p40–defi  cient BMDCs 
to induce activation of antigen-specifi  c T cells
We have demonstrated that the ability of Mtb-activated DCs 
to respond to homeostatic chemokines is dependent on IL-
12p40 and that this activity can be restored in IL-12p40–
  defi   cient DCs by the addition of IL-12(p40)2 (Fig. 6 c). 
We next asked whether treatment of Mtb-exposed IL-12p40–
defi  cient DCs with IL-12(p40)2 could rescue T cell activation 
and priming in the LN. To do this we incubated IL-12p40–
defi  cient BMDCs with Mtb, OVA323–339, and IL-12(p40)2 for 
3 h, transferred these cells to the lungs of mice that had re-
ceived a bolus of naive TCRTg T cells 48 h previously, and 
monitored T cell activation in the DLNs. We show here that 
antigen-specifi  c  CD4+ T cells accumulate in signifi  cantly 
higher numbers in the DLNs of mice receiving the IL-
12(p40)2–treated, Mtb-exposed IL-12p40–defi  cient  DCs 
than in mice receiving untreated, Mtb-exposed IL-12p40–
defi  cient DCs (Fig. 8 a). These antigen-specifi  c T cells ex-
pressed high levels of CD44 and CD69, indicative of an 
activated phenotype (Fig. 8 b). In fact, the ability of the 
IL-12(p40)2–treated IL-12p40–defi  cient BMDCs to induce 
  activation and accumulation of antigen-specifi  c cells was 
equivalent to that of the B6 BMDCs. In further support of 
this fi  nding, Mtb-exposed antigen-pulsed BMDCs capable of 
expressing only IL-12p40 are also able to initiate T cell ex-
pansion and activation after intratracheal delivery (Fig. 8, c 
and d), indicating that expression of IL-12p40 alone by DCs 
is suffi   cient to drive T cell activation and expansion. In con-
trast, the availability of IL-12p40 either in dimeric form (Fig. 
8 e) or from p19/p35-defi  cient BMDCs (not depicted) was 
unable to initiate the generation of IFN-γ–producing cells. 
We conclude from these data that IL-12p40 provides suffi   -
cient stimulus to reconstitute the T cell–activating phenotype 
of IL-12p40–defi  cient DCs but that it is insuffi   cient to restore 
a Th1 phenotype within the newly activated T cells. These 
data fi  t with our previous observation that the development 
of Th1 cells in the absence of IL-12p70 is entirely dependent 
on IL-23 (11).
DISCUSSION
We demonstrate a novel and important function for 
IL-12p40 in the initiation of T cell responses. This observa-
tion improves our limited understanding of the factors re-
quired for T cell activation upon microbial challenge to 
the lung. We demonstrate that a key component of Mtb-
  initiated T cell activation is the induction of chemokine re-
sponsiveness in DCs and that this induction is dependent 
on IL-12p40 production by DCs. This requirement for 
IL-12p40 does not refl  ect the need for IL-23 or IL-12p70, as 
Figure 8.  DCs expressing IL-12p40 alone or IL-12p40–defi  cient 
DCs treated with IL-12(p40)2 can activate naive T cells when de-
livered to the lung. BMDCs from B6 or IL-12p40–defi  cient (p40KO) 
mice were treated with irradiated Mtb alone or Mtb in the presence of 
IL-12(p40)2 for 3 h. The cells were pulsed with OVA323–339 and transferred 
intratracheally into B6 mice that had received a bolus of naive CD4 
TCRTg T cells. The number (a) and activation phenotype (b) of 
CD4+CD90.1+ T cells within the DLN at 4 d were determined by fl  ow 
cytometry. BMDCs from B6, IL-12p40–defi  cient (p40KO), or IL-12p35/IL-
23p19–defi  cient (p35/p19KO) mice were treated as described above and 
delivered to mice, and the number (c) and activation phenotype (d) of 
transferred naive T cells were determined at day 4 by fl  ow cytometry. 
ELISPOT was used to determine the total number of antigen-specifi  c 
IFN-γ–producing cells in the DLN for IL-12(p40)2–treated IL-12p40–
defi  cient (p40KO) DCs (e). Data points represent the mean for each 
group (n = 3–4). One experiment representative of three total experi-
ments for each of panels a–e is shown. p-values were determined by the 
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the migratory phenotype is induced in mice lacking these cy-
tokines and can be reconstituted by providing IL-12(p40)2 to 
IL-12p40–defi  cient DCs. The data also support the impor-
tance of pathogen-induced DC migration in the initiation of 
T cell responses after aerosol delivery of antigen.
Pathogen-mediated activation facilitates migration of 
DCs from the periphery to the secondary lymphoid organs, 
and the failure of Mtb-exposed IL-12p40–defi  cient DCs to 
become migratory implicates this cytokine as a key mediator 
of this process. This novel role for IL-12p40 provides a ratio-
nale for the fact that IL-12p40 production is one of the earli-
est events after DC activation (24, 30–32) and that IL-12p40 
is produced more rapidly and in excess of IL-12p70 during 
pulmonary infl  ammation (24–26).
Although migration of DCs to the LN is the fi  rst step in 
initiating T cell responses, DCs must also be able to activate 
naive T cells. Our data showing that DCs making only IL-
12p40 as well as IL-12p40–defi  cient DCs treated with IL-
12(p40)2 can initiate activation of naive T cells confi  rm that 
IL-12p40, probably as the IL-12(p40)2, is suffi   cient to medi-
ate the Mtb-induced maturation of DCs to a T cell–activating 
phenotype. The failure of DCs making only IL-12p40 and of 
IL-12p40–defi  cient DCs treated with IL-12(p40)2 to promote 
eff  ector cell development indicates that polarization of the 
T cell during activation requires, as expected, IL-12p70 and/
or IL-23 (as discussed in reference 11). In a preliminary anal-
ysis of Mtb-infected B6, IL-12p40–defi  cient, and IL-12p35/
IL-23p19–defi  cient mice, we have not detected diff  erences 
in the frequency or number of IL-4– or IL-10–producing 
CD4 T cells in the lungs (not depicted), indicating that ac-
tivation in the presence of IL-12p40 alone does not drive a 
Th2 type of CD4 T cell response.
Our understanding of this novel and important activity of 
IL-12p40 is in its infancy and the mechanisms involved are 
not yet clear. However, the data suggest that events progress 
rapidly. Specifi  cally, changes in chemokine responsiveness 
occur within 3 h, with exogenous IL-12(p40)2 also able to 
restore responsiveness within this timeframe. This rapidity 
means that up-regulation of mRNA for the chemokine 
  receptor CCR7 is unlikely to be the key IL-12(p40)2–
  mediated event. Rather, a change in the ability of the recep-
tor to initiate migration may be more likely. Thus, IL-12(p40)2 
may act to overcome negative signals limiting pulmonary 
DC responsiveness. Interestingly, we see increased IL-10 
mRNA and protein production in IL-12p40–defi  cient DCs, 
and the addition of IL-10 to B6 DCs reduced chemokine re-
sponsiveness to the level seen in IL-12p40–defi  cient DCs. 
Further, IL-10 specifi   cally inhibits migration of DCs to 
CCL19 by uncoupling the CCR7 receptor from protein ki-
nase B phosphorylation (33). Thus, it is plausible that rapid, 
early induction of IL-12(p40)2 in response to a pathogen al-
lows lung DCs to overcome an IL-10–induced inhibition of 
migration. This pathway is further supported by the fact that 
autocrine IL-10 reduces traffi   cking of pulmonary DCs to the 
DLN after mycobacterial infection (34). This pathway may 
also explain the apparently contradictory data showing that 
although DCs in IL-12p35–defi  cient mice exhibit a moder-
ately compromised migratory response to Mtb, IL-12p35–
defi  cient DCs generated in vitro do not show a defect. The 
relative importance of IL-12p70 on Mtb-induced migration 
may thus refl  ect the levels of IL-10 within the in vivo and in 
vitro environments.
We have not determined the receptor(s) by which IL-
12(p40)2 stimulates DCs to become migratory; however, as 
IL-12(p40)2 can induce NF-κB mobilization in myeloid cells 
(18), this cytokine may act directly on DCs to initiate 
  chemokine responsiveness. IL-12(p40)2 likely binds the IL-
12Rβ1 (35); however, as the IL-12Rβ2 chain is the primary 
signal-transducing element of the IL-12R (9) and ligation of 
the IL-12Rβ2 chain requires the presence of IL-12p70 (36, 37), 
it is not clear how IL-12(p40)2 induces responses in myeloid 
cells. However, there are diff  erences in the affi   nity of the 
IL-12R on myeloid and lymphoid cells that may allow IL-
12(p40)2 signaling in myeloid cells (12, 15, 16). We are 
currently investigating the requirement for each IL-12R 
chain in the Mtb-induced migration of pulmonary DCs.
Whether IL-12(p40)2–induced DC migration is specifi  c 
for the lung is not yet known. Increased sensitivity of IL-
12p40–defi   cient mice over IL-12p35–defi   cient mice has 
been seen in Francisella tularensis (38), Cryptococcus neoformans 
(39), Salmonella enteriditis (40), and Mycobacterium bovis BCG 
(2). In none of the above studies was the initiation of cellular 
response studied; therefore, it is unclear whether these mod-
els refl  ect a role for IL-12p40 in either pulmonary or other 
DC function. We are currently extending our studies to de-
termine whether IL-12p40 is required for migration of DCs 
from the skin. This is particularly interesting in light of the 
recent publication showing that human skin migratory DCs 
produce IL-12p40 and can stimulate allogeneic T cells in the 
absence of IL-12p70 (41). In contrast, we think that if anti-
gen is systemic, IL-12p40–mediated DC migration is not re-
quired. This is supported by the fact that IL-12p40–defi  cient 
DCs can initiate T cell activation as effi   ciently as normal DCs 
in culture and when injected intravenously (shown here and 
in reference 42). Similarly, after Toxoplasma gondii infection, 
the activation of CD4 T cells is equivalent in B6, IL-12p35–
defi  cient, and IL-12p40–defi  cient mice (43), suggesting that 
when a potent and systemic infection occurs, the role of IL-
12p40 in DC migration is not required.
The data presented here impact our understanding of 
the natural history of Mtb infection and the initiation of 
the   immune response in the lung after microbial challenge. 
The data also have ramifi  cations for the generation of vac-
cines that act via the pulmonary route, in that IL-12p40 may 
prove to be an eff  ective adjuvant for the initiation of T cell 
  responses in the lung.
MATERIALS AND METHODS
Animals. C57BL/6J (B6), IL-12p35–defi  cient  (B6.Il12a−/−, IL-12p35–
  defi  cient) and IL-12p40–defi  cient (B6.Il12b−/−, IL-12p40–defi  cient) mice 
were purchased from The Jackson Laboratory. IL-23p19 gene-disrupted 
mice (B6.Il23a−/−, IL-23p19–defi  cient) were generated at Genentech Inc. 
by F. deSauvage and N. Ghilardi as described previously (44). Mice lacking JEM VOL. 203, July 10, 2006  1813
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both IL-12p35 and IL-23p19 (B6.Il12a−/−xIl23a−/−, IL-12p35–/IL-23p19–
defi  cient) were generated at the Trudeau Institute as described previously 
(11). The genotype and phenotype of the gene-defi  cient mice are presented 
in Table I. OT-II αβTCRTg male mice (OT-II), which are MHC class II 
I-Ab restricted and specifi  c for OVA323–339 (45) were obtained from the 
Trudeau Institute Inc.’s Animal Breeding Facility. Experimental mice were 
age and sex matched and used between the ages of 8 and 12 wk. Mice were 
used in accordance with the Institutional Animal Care and Use Committee 
guidelines of the National Research Council and the Trudeau Institute.
Experimental infection. The H37Rv strain of Mtb was grown in Pros-
kauer Beck medium containing 0.05% Tween 80 to mid-log phase and fro-
zen in 1-ml aliquots at –70°C. For aerosol infections, subject animals were 
infected with  75 bacteria using a Glas-Col airborne infection system as 
  described previously (46).
Lung and DLN cell preparation. The lung tissue was prepared as 
  described previously (46). Single cell suspensions were prepared from either 
digested lung tissue or DLN by dispersing the tissue through a 70-μm 
  nylon tissue strainer (BD Falcon). The resultant suspension was treated with 
Geys solution to remove any residual red blood cells, washed twice, and 
counted (46).
Detection of IFN-𝗄–producing cells by ELISPOT assay. Antigen-
specifi  c IFN-γ–producing CD4 T cells from infected lungs or DLNs were 
counted using peptide-driven ELISPOT as described previously (11). 
In brief, wells were coated with monoclonal anti–mouse IFN-γ and blocked. 
Cells from lungs and DLNs were seeded at an initial concentration of 105 
cells/well and diluted. Irradiated B6 splenocytes were used as APC at a con-
centration of 106 cells/well along with 10 μg/ml ESAT-61–20 (47, 48) or 
5 μM OVA323–339 peptide and IL-2. After 24 h, plates were washed and 
probed with biotinylated anti–mouse IFN-γ. Spots were visualized and enu-
merated visually under a dissection microscope. Neither cells cultured in the 
absence of antigen nor cells from uninfected mice produced detectable spots.
Generation of BMDCs. DCs were generated from the bone marrow of 
B6 and gene-defi  cient mice as described previously (49). In brief, cells were 
extracted from the femurs of mice and cultured in supplemented DMEM 
(sDMEM) containing 10% FBS and 20 ng/ml of recombinant murine GM-
CSF (rmGM-CSF; PeproTech). On days 3, 6, and 8, cultures were supple-
mented with additional sDMEM. On day 10 of culture, nonadherent cells 
were collected by centrifugation and used as BMDCs. ELISA was used to 
measure the production of IL-10 and IL-12p40 by BMDCs exposed to Mtb. 
Some Mtb-activated BMDCs were cultured with 500 ng/ml IL-12(p40)2, 
500 ng/ml IL-12(p40)2 denatured by boiling for 20 min, 500 ng/ml 
IL-12p70, or 10 ng/ml IL-10 (all from R&D Systems).
In vivo tracking of BMDCs. Day 10 in vitro–generated BMDCs were 
used for in vivo tracking as described previously (50, 51). In brief, BMDCs 
were activated in vitro with 500 μg/ml of irradiated Mtb H37Rv whole 
cells (obtained under National Institutes of Health [NIH] contract AI-75320) 
and 5 μM OVA323–339 peptide for 3 h. Cells were washed once and stained 
with 6 μg/ml TAMRA orange (Invitrogen) for 3 min at 37°C, whereupon 
they were washed and resuspended in PBS. 106 Mtb-exposed OVA323–339-
pulsed BMDCs were then instilled intratracheally into B6 mice, and at vari-
ous times after instillation, lungs and DLNs were harvested and processed to 
produce single cell suspensions.
In vivo tracking of lung CD11c+ DCs. Some mice received a suspension 
of 5 μg of irradiated Mtb in a 5-mM CFSE (Invitrogen) solution delivered 
intratracheally, whereas other mice received 5 μg/ml LPS in 5 mM CFSE. 
Control mice received CFSE alone. 18 h after instillation, both the lung and 
the DLN were harvested, and single cell suspensions were prepared as de-
scribed above. Flow cytometry was used to determine the frequency and 
  total number of CFSE-labeled CD11c+ cells within the lung and DLN.
Naive CD4+ T cell isolation and in vivo eff  ector priming. Naive 
CD4+ T cells were positively sorted from single cell suspensions of the 
spleens and LNs of OT-II αβTCRTg (TCRTg) mice using magnetic beads 
labeled with anti-CD4 antibody (clone GK1.5; Miltenyi Biotec) and a 
MACS column according to the manufacturer’s instructions (Miltenyi Biotec). 
107 T cells (>95% CD4+) were resuspended in 100 μl of physiological saline 
and injected intravenously into B6 mice. 2 d later, host mice were intratra-
cheally instilled with 106 BMDCs activated in vitro with 500 μg/ml of irra-
diated Mtb H37Rv whole cells in the presence of 5 μM of the OVA323–339 
peptide for 3 h. Some BMDCs were also exposed to 500 ng/ml IL-12(p40)2 
during in vitro stimulation. The IL-12(p40)2 was obtained from R&D 
  Systems (499-ML/CF). It is 97% homodimer as determined by SDS-PAGE 
and has <1 EU/μg of endotoxin by the Limulus amoebocyte assay method. 
Control mice received untreated BMDCs, Mtb-treated BMDCs, or OVA-
treated BMDCs alone. On day 4, after intratracheal instillation, the DLNs 
were harvested, single cell suspensions were generated, and the frequency of 
specifi  c cell types was determined by ELISPOT and fl  ow cytometry. Some 
mice received the same BMDCs via the intravenous route, and T cell re-
sponses were monitored by fl  ow cytometry on day 4.
Flow cytometry. Single cell suspensions were stained with fl  uorochrome-
labeled antibodies specifi  c for CD4 (clone GK1.5), CD90.1 (Thy1.1; clone 
HIS51), CD69 (clone HI2F3), CD44 (clone IM7), CD11c (clone HL3), 
MHC class II I-Ab (clone AF6-120.1), CD80 (B7-1; clone 16-10A1), 
CD86 (B7-2; clone GL1), CD40 (clone 145-2C11), and CD11b (clone 
M1/70). Cells were collected using CELLQuest software on a Becton 
Dickinson FACSCalibur fl  ow cytometer. Lymphocytes were gated based 
on their forward and side scatter characteristics, and adoptively transferred 
CD4+ T cells (CD90.1+) were tracked in CD90.2+ congenic hosts. DCs 
were designated as CD11c+ cells that exhibit low autofl  uorescence in the 
FL1 channel as defi  ned previously (28). Lung cells were sorted based on 
CD11c expression and autofl  uorescence using a three-laser FACSVantage 
SE with DIVA option.
Chemotaxis assay. DCs were activated with 500 μg/ml of irradiated Mtb 
for 3 h, and their ability to respond to the chemokines CCL-19 (ELC, or 
EB1 ligand chemokine) or CCL-21 (SLC, or secondary lymphoid organ 
chemokine; both from R&D Systems) was determined using a previously 
described chemotaxis assay (52). In brief, 105 activated BMDCs were added 
to the upper chambers of 24-well transwell plates (Costar) containing a poly-
carbonate fi  lter with a 5-μm pore size. Either CCL-19 or CCL-21 was 
added to the lower chamber and the plates were incubated at 37°C for 
Table I.  Genotype and phenotype of gene-defi  cient mice
Common namea
(fi  gure name)
IL-12p35–defi  cient 
(p35KO)
IL-23p19–defi  cient 
(p19KO)
IL-12p35–/IL-23p19–defi  cient 
(p35/p19KO)
IL-12p40–defi  cient 
(p40KO)
Missing gene Il12a Il23a Il12a, Il23a Il12b
Missing protein p35, IL-12p70 p19, IL-23 p19, p35, IL-12p70, IL-23 p40, IL-12p70, IL-23, 
 IL-12(p40)2
Protein available IL-23, IL-12(p40)2 IL-12p70, IL-12(p40)2 IL-12(p40)2 None
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90 min. The transmigrated cells were collected from the lower chamber, 
fi  xed, and counted on a fl  ow cytometer. To determine the absolute number 
of cells in each sample, a standard number of 20-μm-size fl  uorescent micro-
spheres (Polysciences, Inc.) was added to each tube and counted with the 
cells. The results are expressed as a chemotaxis index, which is calculated as 
the fold increase in the number of migrated cells in response to chemoattrac-
tant over spontaneous migration to control medium.
Real-time PCR. RNA was extracted from BMDCs as described previ-
ously (11). RNA samples (n = 3) were treated with DNase and reverse 
transcribed, cDNA was amplifi   ed using Taqman reagents on the ABI 
Prism 7700 sequence detection system, and fold increase in signal over 
that derived from uninfected BMDCs was determined using the ∆∆ct 
calculation. The primer and probe sequence for murine GAPDH was as 
described previously (11). The sequences for the CCR7 reaction were 
designed and validated by the Trudeau Institute Inc.’s Molecular Biology 
Core Facility and were as follows: forward, 5′-A  C  C  A  T  G  G  A  C  C  C  A  G  G  G-
A  A  A  C  ; reverse, 5′-G  G  T  A  T  T  C  T  C  G  C  C  G  A  T  G  T  A  G  T  C  A  T  ; and probe, 
5′-C  T  T  G  T  C  A  T  T  T  T  C  C  A  G  G  T  G  T  G  C  T  T  C  -TGCCAA.
Statistical analysis. Diff  erences between the means of experimental groups 
were analyzed using the Student’s t test. Diff  erences were considered signifi  -
cant when P ≤ 0.05.
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